MIR670HG

Across TCGA pan-cancer cohorts, MIR670HG Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MIR670HG data layer compared with 16 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher MIR670HG Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR670HG expression acts as an unfavorable survival marker.

ESCA are the cancer types where MIR670HG Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.206	0.686	.004	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

MIR670HG–ESCA (OS)

Open the ESCA breakdown →